Sulpiride

舒必利

Report date: 2023/02/23 20:00:33
NME

Base Information

Drug NameSulpiride
Drug Alias Name舒必来EglonylDolmatilDobrenDogmatyl +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors antagonists
TargetsDopamine receptors
Therapy Area/IndicationsSchizophreniaDepressionVomiting +[5] 
Global Approved IndicationsSchizophreniaDepressionVomiting +[5] 
Approved Indications in ChinaSchizophreniaDepressionVomiting
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryEUMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesChangzhou Pharmaceutical FactoryNichi-Iko Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophreniaDepressionVomiting +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN05AL01
Related LinksWikipediaDrugBankKEGG